1791P A phase I pharmacology study of the dual MDMX/MDM2 inhibitor, ALRN 6924, in healthy volunteers

Autor: Voors-Pette, C., Aalders, W., Brill, M., Ferrari, D., Annis, A., Steidl, U., Aivado, M., Vukovic, V.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S1222-S1223
Databáze: ScienceDirect